Cipla is engaged in the Business of Pharmaceuticals.
Financial Results:
Cipla Ltd reported Revenues for Q1FY25 of ₹6,694.00 Crores up from ₹6,329.00 Crore year on year, a rise of 5.77%.
Total Expenses for Q1FY25 of ₹5,243.00 Crores up from ₹5,090.00 Crores year on year, a rise of 3.01%.
Consolidated Net Profit of ₹1,175.00 Crores up 17.74% from ₹998.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹14.58, up 18.25% from ₹12.33 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.